"Virology" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The study of the structure, growth, function, genetics, and reproduction of viruses, and VIRUS DISEASES.
Descriptor ID |
D014773
|
MeSH Number(s) |
H01.158.273.540.859
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Virology".
Below are MeSH descriptors whose meaning is more specific than "Virology".
This graph shows the total number of publications written about "Virology" by people in this website by year, and whether "Virology" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Below are the most recent publications written about "Virology" by people in Profiles.
-
Assessment of a New Lower-Cost Real-Time PCR Assay for Detection of High-Risk Human Papillomavirus: Useful for Cervical Screening in Limited-Resource Settings? J Clin Microbiol. 2017 08; 55(8):2348-2355.
-
Five-year risk of recurrence after treatment of CIN 2, CIN 3, or AIS: performance of HPV and Pap cotesting in posttreatment management. J Low Genit Tract Dis. 2013 Apr; 17(5 Suppl 1):S78-84.
-
Follow-up testing after colposcopy: five-year risk of CIN 2+ after a colposcopic diagnosis of CIN 1 or less. J Low Genit Tract Dis. 2013 Apr; 17(5 Suppl 1):S69-77.
-
Five-year risk of CIN 3+ to guide the management of women aged 21 to 24 years. J Low Genit Tract Dis. 2013 Apr; 17(5 Suppl 1):S64-8.
-
Five-year risks of CIN 3+ and cervical cancer among women who test Pap-negative but are HPV-positive. J Low Genit Tract Dis. 2013 Apr; 17(5 Suppl 1):S56-63.
-
Five-year risks of CIN 3+ and cervical cancer among women with HPV-positive and HPV-negative high-grade Pap results. J Low Genit Tract Dis. 2013 Apr; 17(5 Suppl 1):S50-5.
-
Five-year risks of CIN 2+ and CIN 3+ among women with HPV-positive and HPV-negative LSIL Pap results. J Low Genit Tract Dis. 2013 Apr; 17(5 Suppl 1):S43-9.
-
Five-year risks of CIN 3+ and cervical cancer among women with HPV testing of ASC-US Pap results. J Low Genit Tract Dis. 2013 Apr; 17(5 Suppl 1):S36-42.
-
Benchmarking CIN 3+ risk as the basis for incorporating HPV and Pap cotesting into cervical screening and management guidelines. J Low Genit Tract Dis. 2013 Apr; 17(5 Suppl 1):S28-35.